Skip to main content

and
  1. Article

    Open Access

    Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer

    Recently, fibroblast growth factor receptor 1 (FGFR1) was discovered in squamous cell carcinomas (SCC) of the lung with FGFR1 amplification described as a promising predictive marker for anti-FGFR inhibitor treat...

    N Cihoric, S Savic, S Schneider, I Ackermann, M Bichsel-Naef in British Journal of Cancer (2014)

  2. Article

    Open Access

    S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

    S100A2 gene products were shown to be frequently and dramatically over-represented in non-small cell lung cancer (NSCLC) lesions over normal tissue by microarray analysis. We have now analysed an independent s...

    S L Smith, M Gugger, P Hoban, D Ratschiller, S G Watson in British Journal of Cancer (2004)

  3. Article

    Open Access

    The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

    Genes of the polycomb group function by silencing homeotic selector genes that regulate embryogenesis. In mice, downregulation of one of the polycomb genes, bmi-1, leads to neurological alterations and severe ...

    S Vonlanthen, J Heighway, H J Altermatt, M Gugger, A Kappeler in British Journal of Cancer (2001)